Clinical Trial Update: Gemcitabine/Cisplatin Plus Cemiplimab With or Without Fianlimab in Localized Muscle-invasive Bladder Cancer (NeoSTOP-IT) [Phase 2]

View source ↗

Summary

Phase 2 trial NeoSTOP-IT evaluating gemcitabine/cisplatin plus cemiplimab with or without fianlimab in localized muscle-invasive bladder cancer is currently rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Muscle-invasive Bladder Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Cemiplimab (cemiplimab)
• Fianlimab (fianlimab)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Columbia University | Conditions: Bladder Cancer, Muscle-Invasive Bladder Carcinoma | Phase 2 | Status: RECRUITING